Updated:
Sirnaomics
Sirnaomics, a biopharmaceutical company based in Gaithersburg, United States, was founded in 2007. It develops therapeutics for critical human diseases using...
Sirnaomics
Sirnaomics, a biopharmaceutical company based in Gaithersburg, United States, was founded in 2007. It develops therapeutics for critical human diseases using RNA interference technology. The company has secured $278.967 million in total funding.
General information
Firm type
other
Year founded
2007
Location
Region
North America
Country
United States
City
Gaithersburg
Corporate office
Gaithersburg, MD, United States
Additional offices
Las Vegas, NV, United States · Shenzhen, China
Sector focus
Frequently asked questions
Who runs investment decisions at Sirnaomics?
The firm does not publicly disclose a single named investment principal. As a clinical-stage biopharmaceutical company, capital allocation decisions are made by its professional management team, likely under the oversight of the board of directors (per the firm).
Does Sirnaomics operate as a family office or a biopharma company?
Sirnaomics is a publicly traded clinical-stage biopharmaceutical company, not a family office. It is included here due to its organizational structure and investment allocation via its corporate capital.
What investment stages does Sirnaomics typically target?
Sirnaomics allocates capital to internal R&D and clinical trials for its own pipeline, rather than making external investments. Its stage coverage spans preclinical through Phase IIb clinical trials, as seen with programs like STP705 and STP122G (per the firm).
Which sectors does Sirnaomics explicitly avoid?
The firm focuses exclusively on RNA therapeutics for cancers, fibrosis, antivirals, cardiometabolic diseases, and medical aesthetics. It has no disclosed exposure to traditional asset classes like real estate, private equity, or hedge funds.
How does Sirnaomics source proprietary deal flow?
Sirnaomics does not source external deal flow; its pipeline is built internally using its two proprietary delivery platforms, PNP and GalNAc (per the firm).
Is Sirnaomics structured as a single family office or does it operate more like a venture firm?
Sirnaomics is a clinical-stage biopharmaceutical company with a corporate structure. It does not operate as a single or multi-family office, nor as a venture firm.
Does Sirnaomics participate in fund commitments or only direct deals?
Sirnaomics does not commit to external funds; its capital is deployed directly into its own R&D and clinical development programs.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: